Aura Biosciences Inc. – Material Contracts Watch

EX-10.5

from 10-Q 13 pages Stock Purchase Agreement

12/34/56

EX-10.4

from 10-Q 2 pages Amendment No. 1 to the 2021 Stock Option and Incentive Plan C-1

12/34/56

EX-10.3

from 10-Q 9 pages April 30, 2026 Personal and Confidential Elisabet De Los Pinos Re: Separation Agreement Dear Ms. De Los Pinos: This Letter Confirms the Termination of Your Employment With Aura Biosciences, Inc. (The “Company”), Effective April 30, 2026 (The “Separation Date”)

12/34/56

EX-10.2

from 10-Q 6 pages May 1, 2026 Personal and Confidential Elisabet De Los Pinos Re: Amended & Restated Consulting Agreement Dear Ms. De Los Pinos

12/34/56

EX-10.1

from 10-Q 7 pages April 29, 2026 Natalie Holles Email: [***]

12/34/56

EX-10.1

from 8-K 4 pages Aura Biosciences, Inc. Amended and Restated Non-Employee Director Compensation Policy

12/34/56

EX-10.1

from 10-Q 9 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark “[***]”. Second Amendment to License Agreement

12/34/56

EX-10.1

from 10-Q 4 pages Aura Biosciences, Inc. Amended and Restated Non-Employee Director Compensation Policy

12/34/56

EX-10.1

from 10-Q 6 pages May 9, 2025 Anthony Gibney [***] [***]

12/34/56

EX-10.14

from 10-K 3 pages Certain Identified Information Has Been Excluded From This Exhibit Because It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Information That Was Omitted Has Been Noted in This Document With a Placeholder Identified by the Mark “[***]”. First Amendment to License Agreement

12/34/56

EX-10.9

from 10-K 4 pages August 19, 2015 Amy Elazzouzi [***] [***] Re: Offer of Employment Dear Ms. Elazzouzi: Following Up on Our Discussions, the Following Represents Our Offer Regarding Your Employment by Aura Biosciences, Inc. (The "Company") as a Full-Time, “At Will” Employee. Your Title and Position Will Be Corporate Controller and You Will Report to the Chief Financial Officer or His Designee. the Scope of Your Responsibilities Will Be Those Customarily Associated With the Position of Corporate Controller. the Basic Terms of Your Employment Are as Follows

12/34/56

EX-10.3

from 10-Q 14 pages Aura Biosciences, Inc. Executive Severance Plan 1

12/34/56

EX-10.2

from 10-Q 5 pages September 25, 2024 Personal and Confidential Julie Feder Re: Resignation and Consulting Agreement Dear Ms. Feder

12/34/56

EX-10.1

from 10-Q 10 pages September 25, 2024 Personal and Confidential Julie Feder Re: Transition and Release Agreement Dear Ms. Feder

12/34/56

EX-10.1

from 10-Q 4 pages Aura Biosciences, Inc. Amended and Restated Non-Employee Director Compensation Policy

12/34/56

EX-10.1

from 10-Q 7 pages Salary and Expenses: Your Compensation Will Be a Starting Salary of Four-Hundred and Forty Thousand ($440,000.00) Dollars Per Annum Subject to Any Company Discretionary Increase, (The “Base Salary”), Which Will Be Paid Bi-Weekly or in Accordance With the Company’s Normal Payroll Practices in Effect From Time to Time. in Accordance With Company Policies and Procedures, You Will Be Reimbursed for All Reasonable Out-Of-Pocket Expenses Incurred by You on Behalf of the Company, in Accordance With Company Policy. 2. Annual Bonuses

12/34/56

EX-10.17

from 10-K 7 pages Salary and Expenses: Your Compensation Will Be a Starting Salary of Four-Hundred and Fifty-Five Thousand ($455,000.00) Dollars Per Annum Subject to Any Company Discretionary Increase, (The “Base Salary”), Which Will Be Paid Bi-Weekly or in Accordance With the Company’s Normal Payroll Practices in Effect From Time to Time. in Accordance With Company Policies and Procedures, You Will Be Reimbursed for All Reasonable Out-Of-Pocket Expenses Incurred by You on Behalf of the Company, in Accordance With Company Policy. 2. Annual Bonuses

12/34/56

EX-10.4

from 10-Q 10 pages Personal and Confidential Dr. Cadmus Rich Re: Transition and Release Agreement • the Company Shall Pay You Salary, Any Accrued but Unused Vacation, and Unpaid and Properly Documented Business Expenses Accrued to You Through the Last Day of Your Employment

12/34/56

EX-10.3

from 10-Q 5 pages Personal and Confidential Dr. Cadmus Rich Re: Resignation and Consulting Agreement

12/34/56

EX-10.2

from 10-Q 9 pages September 26, 2023 Personal and Confidential Dr. Cadmus Rich Re: Transition and Release Agreement • the Company Shall Pay You Salary, Any Accrued but Unused Vacation, and Unpaid and Properly Documented Business Expenses Accrued to You Through the Last Day of Your Employment

12/34/56